| __timestamp | Lantheus Holdings, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 5496000 |
| Thursday, January 1, 2015 | 78634000 | 9786000 |
| Friday, January 1, 2016 | 75374000 | 6792000 |
| Sunday, January 1, 2017 | 92157000 | 7313000 |
| Monday, January 1, 2018 | 93326000 | 8382000 |
| Tuesday, January 1, 2019 | 103132000 | 10803000 |
| Wednesday, January 1, 2020 | 110171000 | 12944000 |
| Friday, January 1, 2021 | 218817000 | 21967000 |
| Saturday, January 1, 2022 | 233827000 | 32810000 |
| Sunday, January 1, 2023 | 267194000 | 46542000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Lantheus Holdings, Inc. and Xenon Pharmaceuticals Inc. offer a fascinating study in contrasts. Over the past decade, Lantheus has seen its SG&A expenses grow by approximately 270%, from $72 million in 2014 to $267 million in 2023. In contrast, Xenon Pharmaceuticals has maintained a more modest increase of around 750%, from $5.5 million to $46.5 million over the same period.
While Lantheus's expenses are significantly higher, reflecting its larger scale, Xenon's more controlled growth in SG&A costs suggests a strategic focus on efficiency. This comparison highlights the diverse strategies companies employ to balance growth and cost management, offering valuable insights for investors and industry analysts alike.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Xenon Pharmaceuticals Inc.
GSK plc and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Alnylam Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Genmab A/S vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Xenon Pharmaceuticals Inc. Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. vs MorphoSys AG: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.